Moreb JS - Search Results

1

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation.

Sugrue MW, Williams K, Pollock BH, Khan S, Peracha S, Wingard JR, Moreb JS. Sugrue MW, et al. Among authors: moreb js. Leuk Lymphoma. 2000 Nov;39(5-6):509-19. doi: 10.3109/10428190009113381. Leuk Lymphoma. 2000. PMID: 11342334 Clinical Trial.

2

Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study.

Liu H, Yuan C, Heinerich J, Braylan R, Chang M, Wingard J, Moreb J. Liu H, et al. Leuk Lymphoma. 2008 Feb;49(2):306-14. doi: 10.1080/10428190701813018. Leuk Lymphoma. 2008. PMID: 18231918

3

Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation.

Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Wingard JR, Moreb JS. Gordan LN, et al. Among authors: moreb js. Leuk Lymphoma. 2003 May;44(5):815-20. doi: 10.1080/1042819031000067585. Leuk Lymphoma. 2003. PMID: 12802919

4

The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost.

Sugrue MW, Hutcheson CE, Fisk DD, Roberts CG, Mageed A, Wingard JR, Moreb JS. Sugrue MW, et al. Among authors: moreb js. J Hematother. 1998 Oct;7(5):431-6. doi: 10.1089/scd.1.1998.7.431. J Hematother. 1998. PMID: 9829317

5

Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.

Waples JM, Moreb JS, Sugrue M, Belanger G, Kubilis P, Lynch JW, Gian V, Weeks F, Wingard J. Waples JM, et al. Among authors: moreb js. Bone Marrow Transplant. 1999 May;23(9):867-73. doi: 10.1038/sj.bmt.1701731. Bone Marrow Transplant. 1999. PMID: 10338040

6

Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival.

Khan SA, Gaa B, Pollock BH, Shea B, Reddy V, Wingard JR, Moreb JS. Khan SA, et al. Among authors: moreb js. Biol Blood Marrow Transplant. 2001;7(8):433-8. doi: 10.1016/s1083-8791(01)80010-0. Biol Blood Marrow Transplant. 2001. PMID: 11569888 Free article.

7

Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma.

Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Moreb JS. Gordan LN, et al. Among authors: moreb js. Bone Marrow Transplant. 2003 Jun;31(11):1009-13. doi: 10.1038/sj.bmt.1704050. Bone Marrow Transplant. 2003. PMID: 12774052

8

High-Dose Chemotherapy with Autologous Stem Cell Rescue as a Treatment Modality for Breast Cancer.

Wingard JR, Moreb JS, Gaa RI. Wingard JR, et al. Among authors: moreb js. Breast J. 1999 Sep;5(5):308-318. doi: 10.1046/j.1524-4741.1999.00004.x. Breast J. 1999. PMID: 11348307

9

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.

Cogle CR, Moreb JS, Leather HL, Finiewicz KJ, Khan SA, Reddy VS, Wingard JR. Cogle CR, et al. Among authors: moreb js. Am J Hematol. 2003 Jul;73(3):169-75. doi: 10.1002/ajh.10342. Am J Hematol. 2003. PMID: 12827653 Free article.

10

Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.

Katragadda L, McCullough LM, Dai Y, Hsu J, Byrne M, Hiemenz J, May S, Cogle CR, Norkin M, Brown RA, Wingard JR, Chang M, Moreb JS. Katragadda L, et al. Among authors: moreb js. Clin Transplant. 2016 Aug;30(8):894-900. doi: 10.1111/ctr.12762. Epub 2016 Jun 29. Clin Transplant. 2016. PMID: 27219740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters